Literature DB >> 10071955

Psammaplin A, a natural bromotyrosine derivative from a sponge, possesses the antibacterial activity against methicillin-resistant Staphylococcus aureus and the DNA gyrase-inhibitory activity.

D Kim1, I S Lee, J H Jung, S I Yang.   

Abstract

Psammaplin A, a natural bromotyrosine derivative from an associated form of two sponges (Poecillastra sp. and Jaspis sp.) was found to possess the antimicrobial effect on the Gram-positive bacteria, especially on methicillin-resistant Staphylococcus aureus (MRSA). The minimal inhibitory concentration of psammaplin A against twenty one MRSAs ranged from 0.781 to 6.25 microg/ml, while that of ciprofloxacin was 0.391-3.125 microg/ml. Psammaplin A could not bind to penicillin binding protein, but inhibited the DNA synthesis and the DNA gyrase activity with the respective 50% (DNA synthesis) and 100% (DNA gyrase) inhibitory concentration 2.83 and 100 microg/ml. These results indicate that psammaplin A has a considerable antibacterial activity, although restricted to a somewhat narrow range of bacteria, probably by inhibiting DNA gyrase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10071955     DOI: 10.1007/bf02976431

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  15 in total

Review 1.  The marine bromotyrosine derivatives.

Authors:  Jiangnan Peng; Jing Li; Mark T Hamann
Journal:  Alkaloids Chem Biol       Date:  2005

Review 2.  Status and perspective of sponge chemosystematics.

Authors:  Dirk Erpenbeck; Rob W M van Soest
Journal:  Mar Biotechnol (NY)       Date:  2006-07-03       Impact factor: 3.619

3.  Psammaplin a improves development and quality of somatic cell nuclear transfer mouse embryos.

Authors:  Anna Mallol; Josep Santaló; Elena Ibáñez
Journal:  Cell Reprogram       Date:  2014-07-28       Impact factor: 1.987

4.  Marine sponge alkaloids as a source of anti-bacterial adjuvants.

Authors:  Roberta J Melander; Hong-Bing Liu; Matthew D Stephens; Carole A Bewley; Christian Melander
Journal:  Bioorg Med Chem Lett       Date:  2016-11-09       Impact factor: 2.823

5.  Thiol- and Disulfide-Containing Vancomycin Derivatives Against Bacterial Resistance and Biofilm Formation.

Authors:  Inga S Shchelik; Karl Gademann
Journal:  ACS Med Chem Lett       Date:  2021-10-18       Impact factor: 4.345

6.  Psammaplin A inhibits hepatitis C virus NS3 helicase.

Authors:  Kazi Abdus Salam; Atsushi Furuta; Naohiro Noda; Satoshi Tsuneda; Yuji Sekiguchi; Atsuya Yamashita; Kohji Moriishi; Masamichi Nakakoshi; Masayoshi Tsubuki; Hidenori Tani; Junichi Tanaka; Nobuyoshi Akimitsu
Journal:  J Nat Med       Date:  2013-01-29       Impact factor: 2.343

7.  Seasonal Variation in Antimicrobial Activity of Crude Extracts of Psammaplysilla sp. 1 from Phillips Reef, South Africa.

Authors:  Wasswa Cuthbert Kibungu; Justine Fri; Anna-Maria Clarke; Anthony Otigbu; Henry Akum Njom
Journal:  Int J Microbiol       Date:  2021-05-11

Review 8.  Naturally occurring small molecule compounds that target histone deacetylases and their potential applications in cancer therapy.

Authors:  Yuki Maemoto; Yuki Shimizu; Ryu Katoh; Akihiro Ito
Journal:  J Antibiot (Tokyo)       Date:  2021-08-23       Impact factor: 2.649

9.  Antiplasmodial activities of homogentisic acid derivative protein kinase inhibitors isolated from a Vanuatu marine sponge Pseudoceratina sp.

Authors:  Nicolas Lebouvier; Valérie Jullian; Isabelle Desvignes; Séverine Maurel; Arnaud Parenty; Dominique Dorin-Semblat; Christian Doerig; Michel Sauvain; Dominique Laurent
Journal:  Mar Drugs       Date:  2009-11-23       Impact factor: 5.118

10.  Cytotoxicity of psammaplin A from a two-sponge association may correlate with the inhibition of DNA replication.

Authors:  Yahong Jiang; Eun-Young Ahn; Seung Hee Ryu; Dong-Kyoo Kim; Jang-Su Park; Hyun Joo Yoon; Song You; Burm-Jong Lee; Dong Seok Lee; Jee H Jung
Journal:  BMC Cancer       Date:  2004-09-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.